Potential New Therapeutic Options in Behçet's Syndrome

ISSN： 1173-8804

Source： BioDrugs, Vol.15, Iss.1, 2001-01, pp. : 25-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?

Current Drug Therapy, Vol. 2, Iss. 3, 2007-09 ,pp. : 177-195

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Toleragens in the Management of Antiphospholipid Syndrome

By Keith A. Cockerill G. Michael Iverson David S. Jones Matthew D. Linnik

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 297-305

Adis International

Access to resources Recommend Favorite

Estrogen and Skin: Therapeutic Options

By >

American Journal of Clinical Dermatology, Vol. 12, Iss. 5, 2011-10 ,pp. : 297-311

Adis International

Access to resources Recommend Favorite

Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome: Progress to Date

By Chang Zhijie

BioDrugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Intestinal Behçets Disease: Epidemiology, Pathophysiology and Potential of Mesalazine

By Kitauchi S.

BioDrugs, Vol. 13, Iss. 6, 2000-06 ,pp. : 409-413

Adis International

Access to resources Recommend Favorite